The use of animal free collagen could significantly lower the development costs of a medical device

The use of animal free recombinant collagen, rather than collagen extracted from animals, could significantly lower the development costs of a medical device by not contributing to the device regulatory classification so that the device is deemed Class II rather than an automatic Class III. Read the news release here: Mobile users click the link […]